Basic Search  |  Summaries  |  Advanced Search

5 Violation Tracker UK results found

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML (maximum 1000; for access to larger downloads contact Phil Mattera)
CompanyParentParent Major IndustryOffence TypeYearAgencyPenalty Amount sort icon
Advanz PharmaNordic Capitalprivate equity (including portfolio companies)price-fixing or anti-competitive practices2021UK-CMA£40,900,000
Focus Pharmaceuticals Limited and Mercury Pharma Group Ltd. and Concordia Investments (Jersey) Ltd. and Advanz Pharma Corp. Ltd. et al.Nordic Capitalprivate equity (including portfolio companies)price-fixing or anti-competitive practices2022UK-CMA£7,288,853
Focus Pharmaceuticals Limited and Mercury Pharma Group Ltd. and Cinven Partners LLP et al.Nordic Capitalprivate equity (including portfolio companies)price-fixing or anti-competitive practices2022UK-CMA£1,843,380
Focus Pharmaceuticals Ltd. and Focus Pharma Holdings Ltd. and Mercury Pharma Group Ltd.Nordic Capitalprivate equity (including portfolio companies)price-fixing or anti-competitive practices2022UK-CMA£921,357
Focus Pharmaceuticals Limited and Focus Pharma Holdings LimitedNordic Capitalprivate equity (including portfolio companies)price-fixing or anti-competitive practices2022UK-CMA£549,343